Baldwin Wealth Partners’s HCA Healthcare HCA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q4
Sell
-123
Closed -$50K 573
2024
Q3
$50K Buy
+123
New +$45K ﹤0.01% 554
2022
Q3
Sell
-1,700
Closed -$286K 683
2022
Q2
$286K Hold
1,700
0.04% 153
2022
Q1
$426K Sell
1,700
-500
-23% -$126K 0.05% 136
2021
Q4
$565K Hold
2,200
0.06% 114
2021
Q3
$534K Buy
+2,200
New +$538K 0.06% 106
2016
Q4
Sell
-244
Closed -$18K 520
2016
Q3
$18K Buy
+244
New +$18.7K ﹤0.01% 391

Other funds holding HCA

Baldwin Wealth Partners's HCA Position: Q4 2024 in Review

Baldwin Wealth Partners sold out of HCA Healthcare (HCA) in Q4 2024, closing a stake of 123 shares — an estimated $50K sold.

Baldwin Wealth Partners first reported a position in HCA in Q3 2016 and held it in 6 quarters. The position peaked at $565K in Q4 2021. 1,180 funds tracked by Wall St. Rank hold HCA as of Q4 2024.

  • Baldwin Wealth Partners reported no remaining HCA Healthcare position as of Q4 2024 after selling out during the quarter.
  • Baldwin Wealth Partners sold 123 HCA Healthcare shares in Q4 2024, an estimated $50K.
  • Baldwin Wealth Partners first reported a position in HCA Healthcare in Q3 2016 and held it in 6 quarters.
  • Baldwin Wealth Partners's HCA Healthcare position peaked at $565K in Q4 2021.
  • 1,180 funds tracked by Wall St. Rank held HCA Healthcare as of Q4 2024.

Based on Baldwin Wealth Partners's 13F filing for Q4 2024, filed 22 Jan 2025.